Trial intelligence / Profile preview

Efficacy and safety of Aethoxysklerol versus Sodium Tetradecyl Sulfate and placebo for reticular and spider veins

2006-004565-33Phase 3Completed

Sponsor
Kreussler
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of 10XB101 in Varicose Veins (3 arms), sponsored by Kreussler. Primary endpoint: Primary efficacy endpoint. Started Jan 2007; status: completed.

02

Drugs

10XB101
03

Conditions

Varicose Veins

Beyond the preview

Go deeper on 2006-004565-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004565-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call